A UK expert will discuss ground-breaking research into several new-generation alzheimer’s medications at this year’s Arab Health event.
The research will be presented by Harley Street’s Dr MacSweeney, co-founder and CEO of Re:Cognition Health’s Brain & Mind Centers.
Re:Cognition Health’s experts have been intimately involved in several groundbreaking clinical trials for the effective new generation treatments, with the first of these entering the market, and many more currently in development, in global clinical trials.
Dr MacSweeney will offer his cautiously optimistic outlook for early-stage alzheimer’s and how the definition of the disease has changed completely in the light of recent scientific advances.
This will include the results from Eli Lilly’s TRAILBLAZER-ALZ 2 study for Donanemab and Eisai’s “CLARITY” Study for Lecanemab.
Both studies trialed new monoclonal antibodies against toxic brain amyloid protein, which successfully slowed the progression of alzheimer’s Disease and its symptoms.
The TauRx LUCIDITY study also demonstrated promising results for a new medication aimed against toxic tau protein in the brain.
Dr MacSweeney said: “There is every reason to be cautiously optimistic, as these new-generation medications, available in the UK and in international clinical trials, can potentially change an individual’s future.
“As we grow older, alzheimer’s disease is the most common cause, by far, of the symptoms listed below and there are no medications on the market in the UK to slow the progression of this disease and its symptoms.
“The most accurate diagnosis, globally, can be achieved through screening for a clinical trial and if confirmed to be due to early symptoms of Alzheimer’s Disease, the same trial could provide the opportunity for an effective treatment.”
Furthermore, new medications are available on the market, now, at Re:Cognition Health’s USA Centers and likely to be at their UK location in Harley Street in 2024.
This is alongside multiple newer and potentially even more effective medications still in clinical trial.
Dr Emer MacSweeney will be speaking at Arab Health on January 29 2024 at 2pm at the ABHI Operating Theatre on stand H2 E30.
The expert will also be addressing the biggest Silent Killer in Contact Sports: Chronic Traumatic Encephalopathy (CTE).
Re:Cognition Health will be located on the Harley Street Medical Area stand Hall 2 stand F30.
